[HTML][HTML] The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms

R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle… - Leukemia, 2022 - nature.com
We herein present an overview of the upcoming 5th edition of the World Health Organization
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …

Diagnostic criteria for monoclonal B‐cell lymphocytosis

GE Marti, AC Rawstron, P Ghia… - British journal of …, 2005 - Wiley Online Library
Very low levels of circulating monoclonal B‐cell subpopulations can now be detected in
apparently healthy individuals using flow cytometry. We propose the term 'monoclonal B‐cell …

Human peripheral blood B‐cell compartments: a crossroad in B‐cell traffic

M Perez‐Andres, B Paiva, WG Nieto… - Cytometry Part B …, 2010 - Wiley Online Library
A relatively high number of different subsets of B‐cells are generated through the
differentiation of early B‐cell precursors into mature B‐lymphocytes in the bone marrow (BM) …

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

AC Rawstron, A Orfao, M Beksac, L Bezdickova… - …, 2008 - repub.eur.nl
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first
aimed to identify specific indications for flow cytometry in patients with monoclonal …

[HTML][HTML] Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia

AC Rawstron, FL Bennett, SJM O'Connor… - … England Journal of …, 2008 - Mass Medical Soc
Background A diagnosis of chronic lymphocytic leukemia (CLL) requires a count of over
5000 circulating CLL-phenotype cells per cubic millimeter. Asymptomatic persons with fewer …

Association of minimal residual disease with superior survival outcomes in patients with multiple myeloma: a meta-analysis

NC Munshi, H Avet-Loiseau, AC Rawstron… - JAMA …, 2017 - jamanetwork.com
Importance Numerous studies have evaluated the prognostic value of minimal residual
disease (MRD) in patients with multiple myeloma (MM). Most studies were small and varied …

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

AC Rawstron, N Villamor, M Ritgen, S Böttcher, P Ghia… - Leukemia, 2007 - nature.com
The eradication of minimal residual disease (MRD) in chronic lymphocytic leukaemia (CLL)
predicts for improved outcome. However, the wide variety of MRD techniques makes it …

[PDF][PDF] Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX …

AC Rawstron, JA Child, RM de Tute, FE Davies… - J Clin …, 2013 - researchgate.net
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma:
Impact on Outcome in the Medical Researc Page 1 Minimal Residual Disease Assessed by …

Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

AC Rawstron, MJ Green, A Kuzmicki… - Blood, The Journal …, 2002 - ashpublications.org
Molecular and cellular markers associated with malignant disease are frequently identified
in healthy individuals. The relationship between these markers and clinical disease is not …

Response assessment in W aldenström macroglobulinaemia: update from the VI th I nternational W orkshop

RG Owen, RA Kyle, MJ Stone… - British journal of …, 2013 - Wiley Online Library
This report represents a further update of the consensus panel criteria for the assessment of
clinical response in patients with W aldenström macroglobulinaemia (WM). These criteria …